Texas HB3455 mandates disclosure requirements for experimental drugs and devices and establishes consumer liability against manufacturers for adverse.
Texas HB3455 amends the Health and Safety Code to introduce new disclosure requirements for experimental drugs and devices. Manufacturers must provide purchasers with a disclosure form detailing potential adverse health effects. Health care providers and retailers must give this form to consumers in person and may only sell the drug or device if the consumer, or someone capable of providing informed consent on their behalf, signs the disclosure.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.